Alcohol and Hepatocellular Carcinoma

Area of Science:

• Hepatology
• Oncology
• Public Health

Background:

• Alcohol-associated liver disease (ALD) is a major cause of liver disease globally.
• ALD contributes to a substantial proportion of hepatocellular carcinoma (HCC) cases and deaths.
• ALD-related HCC is less understood than HCC linked to viral hepatitis.

Purpose of the Study:

• To review the epidemiology of ALD-associated HCC.
• To explore co-factors, surveillance, and treatment challenges for ALD-HCC.
• To emphasize the need for improved characterization and management of ALD-related HCC.

Main Methods:

• Literature review of ALD-associated HCC.
• Examination of proposed pathogenic mechanisms (acetaldehyde, oxidative stress, inflammation).
• Analysis of epidemiological data, co-factors (viral hepatitis, metabolic syndrome), and clinical challenges.

Main Results:

• ALD is a leading risk factor for HCC, accounting for one-third of global cases.
• ALD-HCC often presents at advanced stages, complicating treatment and reducing survival.
• Key co-factors and proposed mechanisms require further investigation.

Conclusions:

• ALD-associated HCC represents a significant and undercharacterized public health burden.
• Effective surveillance and treatment strategies for ALD-HCC are lacking.
• Further research is crucial to improve outcomes for patients with ALD-related liver cancer.